Figure 2. Detection of signal pathway expression in clinical ovarian cancer samples and RIP assay. (A, B) Immunohistochemical detection of ITGB2-PI3K-AKT-mTOR in different grades of ovarian cancer tissues (FIGO I-IV) and data statistics. (C, D) RIP assays of signal pathway factors (ITGB2, AKT vs PI3K) and data statistics.